Table 3.
Harmful effects Aβ•CaSR signaling elicits in human neurons and astrocytes.
| Cell type | Stimulus | Pathological effect | Effect of adding calcilytic to Aβs | Effect of calcimimetic alone |
|---|---|---|---|---|
| Neurons, astrocytes | Aβ42-os Aβ fibrils | Overproduction and diffuse intracellular accumulation of endogenous Aβ42 monomers and Aβ42-os due to an increased β-S and γ-S activity and (likely) to decreases in Aβ proteolysis | Total suppression of intracellular accumulation of Aβ42 monomers and Aβ42-os due to increased Aβ-os proteolysis (no effect on increased β-S and γ-S activities) | No apparent intracellular accumulation of Aβs |
| Neurons, astrocytes | Aβ42-os Aβ fibrils | Concurrent Aβ40-os intracellular accumulation | Modest decrease of Aβ40-os intracellular accumulation | n. d.* |
| Neurons, astrocytes | Aβ42-os Aβ fibrils | Surplus secretion of Aβ42-os, but not of Aβ40-os, along the Golgi/trans-Golgi pathway and axons ⇒ extracellular Aβ42/Aβ40 ratios values shift to the cytotoxic range | Total suppression of surplus release of Aβ42-os along the Golgi/trans-Golgi pathway and axons, but increased release of Aβ40-os⇒ extracellular Aβ42/Aβ40 ratios values remain in the normal range (NPS 2143 by itself exerts no effect on basal Aβ42-os secretion) | Significant surplus secretion of Aβ42-os |
| Neurons | Aβ42-os Aβ fibrils | Slow yet progressive death by apoptosis of the human cortical neurons (in vivo this is the cause of cognitive decline; Nelson et al., 2012). | Neurons remain alive and kicking | n. d. |
| Astrocytes | Aβ42-os Aβ fibrils | NAHAs survive and keep making and releasing neuron-harming compounds (see below) | No apparent effect on survival | n. d. |
| Astrocytes | Aβ fibrils | Increased activity of the glycogen synthase kinase (GSK)-3β, one of the main Tau kinases (Armato et al., 2013b). | Total suppression of the surge of GSK-3β activity (Armato et al., 2013b). | n. d. |
| Astrocytes | Aβ42-os Aβ fibrils | Stabilization and nuclear translocation of the HIF-1α•HIF-1β transcription factor ⇒ expression of VEGF-A, APP, and BACE1 genes ⇒ heightened synthesis/secretion of VEGF-A and Aβ42/Aβ42-os | HIF-1α destabilization ⇒ deep yet transient decrease of nuclear HIF-1α•HIF-1β transfer ⇒ no surplus production/release of VEGF-A, APP, and Aβ42/Aβ42-os | n. d. |
| Astrocytes | Aβ42-os, Aβ fibrils | Significant yet transient surge of total CASR protein | Downregulation of total CaSR protein: modest and transient with NPS 2143 alone but fast, intense and persistent with Aβs + NPS 2143 | No change in total CaSR protein |
| Astrocytes | Aβ42-os Aβ fibrils | Induction and MEK/ERK-dependent activation of GTP cyclohydrolase-1 (GCH1) ⇒ production of BH4 (tetrahydrobiopterin) ⇒ dimerization and activation of the concomitantly induced NO synthase (NOS)-2 ⇒ excess release of NO | Inactivation of GCH1 ⇒ lack of BH4 ⇒ no dimerization and activation of the concomitantly induced NO synthase (NOS)-2 ⇒ no overproduction of NO | n. d. |
n.d., not determined.